Merck rises on quarterly results beat
View all comments(0)
Drugmaker Merck's MRK.N shares rise 1.6% to $79.97 premarket
MRK posts Q1 revenue of $15.53 billion, exceeding Wall Street estimates of $15.30 billion - data compiled by LSEG
Co reports Q1 adj. profit of $2.22/share vs analysts' average estimate of $2.14/share
Cuts 2025 profit forecast to $8.82 and $8.97/share, compared to a previous range $8.88 to $9.03/share
MRK says forecast cut was due to charge related to $2 billion licensing agreement with Jiangsu Hengrui Pharmaceuticals to access its heart drug
Co also says forecast includes $200 million impact of tariffs implemented to date by U.S. government on imports from other countries
As of last close, MRK stock down 20.8% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

SK Hynix Surges 15% to New High: HBM Shortage Until 2028, How Much Longer Can AI Memory King Rise?

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.